Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Investigation of Interaction between Deferoxamine and Low Frequency Electromagnetic Field on Angiogenesis in Chick Embryo

Atena Dashtizadeh 1 and Javad Baharara 2 , *
Authors Information
1 Department of Biology, Faculty of Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran
2 Department of Biology, Research Center for Animal Developmental Applied Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: February 28, 2015, 17 (2); e1992
  • Published Online: January 26, 2015
  • Article Type: Research Article
  • Received: April 30, 2013
  • Accepted: May 15, 2013

To Cite: Dashtizadeh A, Baharara J. Investigation of Interaction between Deferoxamine and Low Frequency Electromagnetic Field on Angiogenesis in Chick Embryo, Zahedan J Res Med Sci. 2015 ; 17(2):e1992.

Copyright © 2015, Zahedan University of Medical Sciences. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Materials and Methods
  • 1. Karamysheva AF. Mechanisms of angiogenesis. Biochemistry (Mosc). 2008; 73(7): 751-62[PubMed]
  • 2. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta. 2004; 1654(1): 13-22[DOI][PubMed]
  • 3. Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K. The role of angiogenesis in solid tumours: an overview. Eur J Intern Med. 2009; 20(7): 663-71[DOI][PubMed]
  • 4. Harris AL. Angiogenesis as a new target for cancer control. EJC Supplements. 2003; 1(2): 1-12[DOI]
  • 5. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003; 9(6): 669-76[DOI][PubMed]
  • 6. Bamias A, Dimopoulos MA. Angiogenesis in human cancer: implications in cancer therapy. Eur J Intern Med. 2003; 14(8): 459-69[DOI][PubMed]
  • 7. Beerepoot LV, Shima DT, Kuroki M, Yeo KT, Voest EE. Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res. 1996; 56(16): 3747-51[PubMed]
  • 8. Richardson DR, Kalinowski DS, Lau S, Jansson PJ, Lovejoy DB. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta. 2009; 1790(7): 702-17[DOI][PubMed]
  • 9. Saito K, Suzuki H, Suzuki K. Teratogenic effects of static magnetic field on mouse fetuses. Reprod Toxicol. 2006; 22(1): 118-24[DOI][PubMed]
  • 10. Barnes FS, Greenebaum B. Biological and medical aspects of electromagnetic fields. 2007;
  • 11. Rochalska M. [The effect of electromagnetic fields on living organisms: plants, birds and animals]. Med Pr. 2007; 58(1): 37-48[PubMed]
  • 12. Baharara J, Zahedifar Z. The effect of low-frequency electromagnetic fields on some biological activities of animals. Arak Med Univ J. 2012; 15(66): 80-93
  • 13. Shupak NM, Prato FS, Thomas AW. Therapeutic uses of pulsed magnetic-field exposure: a review. Radio Sci Bull. 2003; 307: 9-32
  • 14. McKay JC, Prato FS, Thomas AW. A literature review: the effects of magnetic field exposure on blood flow and blood vessels in the microvasculature. Bioelectromagnetics. 2007; 28(2): 81-98[DOI][PubMed]
  • 15. Alessi P, Ebbinghaus C, Neri D. Molecular targeting of angiogenesis. Biochim Biophys Acta. 2004; 1654(1): 39-49[DOI][PubMed]
  • 16. Bikfalvi A, Bicknell R. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol Sci. 2002; 23(12): 576-82[DOI]
  • 17. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis. 2007; 38(3): 258-68[DOI][PubMed]
  • 18. Ikeda Y, Tajima S, Yoshida S, Yamano N, Kihira Y, Ishizawa K, et al. Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function. Atherosclerosis. 2011; 215(2): 339-47[DOI][PubMed]
  • 19. Kalinowski DS, Richardson DR. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev. 2005; 57(4): 547-83[DOI][PubMed]
  • 20. Kim BS, Yoon KH, Oh HM, Choi EY, Kim SW, Han WC, et al. Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death. Cell Immunol. 2002; 220(2): 96-106[PubMed]
  • 21. Le NT, Richardson DR. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. Carcinogenesis. 2003; 24(6): 1045-58[DOI][PubMed]
  • 22. Kicic A, Chua AC, Baker E. Effect of iron chelators on proliferation and iron uptake in hepatoma cells. Cancer. 2001; 92(12): 3093-110[PubMed]
  • 23. Lieu PT, Heiskala M, Peterson PA, Yang Y. The roles of iron in health and disease. Mol Aspects Med. 2001; 22(1-2): 1-87[DOI]
  • 24. Buss JL, Torti FM, Torti SV. The role of iron chelation in cancer therapy. Curr Med Chem. 2003; 10(12): 1021-34[PubMed]
  • 25. Ruggiero M, Bottaro DP, Liguri G, Gulisano M, Peruzzi B, Pacini S. 0.2 T magnetic field inhibits angiogenesis in chick embryo chorioallantoic membrane. Bioelectromagnetics. 2004; 25(5): 390-6[DOI][PubMed]
  • 26. Tsai MT, Chang WH, Chang K, Hou RJ, Wu TW. Pulsed electromagnetic fields affect osteoblast proliferation and differentiation in bone tissue engineering. Bioelectromagnetics. 2007; 28(7): 519-28[DOI][PubMed]
  • 27. Zafar-Balanezhad S, Parivar K, Baharara J. The synergic effects of rapamycin and extremely low frequency electromagnetic field on angiogenesis. J Shahr-e-Kord Univ Med Sci. 2009; 11(3): 70-6
  • 28. Baharara J, Ashraf AR, Balanejad S, Samareh-Mosavi S. The inhibitory effect of low frequency electromagnetic field (50HZ) on angiogenesis in choriolantoic membrane of chick. Zahedan J Res Med Sci. 2010; 12(2): 8-12
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments